Ensayos clínicos

8.676 ensayos encontrados

CompletadoClinicalTrials.gov

Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina: a Prospective, Multicenter Cohort Study

OBSERVATIONALInicio: 20 de mar de 2020ID: NCT04611269

CompletadoFase 3ClinicalTrials.gov

A Multi-center Phase III Randomized, Double-blind Placebo-controlled Study of the Cancer Vaccine Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Non-small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease.

INTERVENTIONALInicio: 1 de ene de 2007ID: NCT00409188

CompletadoFase 3ClinicalTrials.gov

COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

INTERVENTIONALInicio: 11 de dic de 2020ID: NCT04652102

CompletadoFase 2ClinicalTrials.gov

A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients With Mild to Moderate Pneumonia Due to COVID-19

INTERVENTIONALInicio: 15 de oct de 2020ID: NCT04523181

CompletadoClinicalTrials.gov

Healthcare-associated Infections in Severe COVID-19 Patients Whit Mechanical Ventilation During 2020

OBSERVATIONALInicio: 1 de mar de 2020ID: NCT04819165

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3 Open-label Clinical Study of Doravirine/Islatravir (DOR/ISL [100 mg/0.25 mg]) Once Daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL (100 mg/0.75 mg) QD in a Phase 3 Clinical Study

INTERVENTIONALInicio: 17 de mar de 2023ID: NCT05766501

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

INTERVENTIONALInicio: 10 de nov de 2023ID: NCT06161571

CompletadoClinicalTrials.gov

Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department, During the Severe Restriction Phase of Lockdown in Buenos Aires. A Cohort Study.

OBSERVATIONALInicio: 6 de may de 2021ID: NCT04900233

CompletadoClinicalTrials.gov

Maraviroc Switch Central Nervous System (CNS) Substudy: a Substudy of MARCH, a Randomised, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc (MVC) as a Switch for Either Nucleoside or Nucleotide Analogue Reverse Transcriptase Inhibitors (N(t)RTI) or Boosted Protease Inhibitors (PI/r) in HIV-1 Infected Individuals With Stable, Well-controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of Combination Antiretroviral Therapy (cART).

OBSERVATIONALInicio: 1 de jun de 2012ID: NCT01637233

DesconocidoFase 4ClinicalTrials.gov

A Phase 4, Single Arm, Open Label, Pilot Study of Maraviroc (Celsentri) in Combination With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients.

INTERVENTIONALInicio: 1 de feb de 2010ID: NCT01013987

CompletadoFase 2ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

INTERVENTIONALInicio: 20 de ago de 2021ID: NCT04882878

CompletadoFase 2ClinicalTrials.gov

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults With Acute Respiratory Syncytial Virus Infection Who Are at High Risk for Complications

INTERVENTIONALInicio: 29 de nov de 2022ID: NCT05568706

CompletadoFase 2ClinicalTrials.gov

A Phase IIb Randomized, Partially Blinded, Dose-Finding Trial of TMC278 in Antiretroviral-Naive HIV-1 Infected Subjects

INTERVENTIONALInicio: 1 de jun de 2005ID: NCT00110305

ReclutandoFase 3ClinicalTrials.gov

A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

INTERVENTIONALInicio: 13 de sept de 2022ID: NCT05531565

CompletadoFase 3ClinicalTrials.gov

A Randomized Open-label Study of the Antiviral Efficacy and Safety of Atazanavir Versus Lopinavir/Ritonavir(LPV/RTV), Each in Combination With Two Nucleosides in Subjects Who Have Experienced Virologic Failure With Prior Protease Inhibitor-Containing HAART Regimen(s)

INTERVENTIONALInicio: 1 de feb de 2001ID: NCT00028301

CompletadoFase 3ClinicalTrials.gov

A Randomized, Controlled, Double-Blind Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of GP2013 vs. MabThera® in Patients With Previously Untreated, Advanced Stage Follicular Lymphoma

INTERVENTIONALInicio: 1 de dic de 2011ID: NCT01419665

ReclutandoClinicalTrials.gov

Argentinean Registry on the Management of Helicobacter Pylori Infection

OBSERVATIONALInicio: 17 de may de 2021ID: NCT06579365

CompletadoFase 3ClinicalTrials.gov

Phase III Randomized, Controlled, Open-label Trial to Investigate the Antiviral Activity, Tolerability and Safety of TMC114/r in Treatment- Naive HIV-1 Infected Patients.

INTERVENTIONALInicio: 1 de sept de 2005ID: NCT00258557

CompletadoFase 2ClinicalTrials.gov

Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of the Administration of RUTI® Immunotherapy With the Standard Treatment in Patients With Tuberculosis

INTERVENTIONALInicio: 29 de oct de 2022ID: NCT05455112

DesconocidoFase 2ClinicalTrials.gov

An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients

INTERVENTIONALID: NCT00017992